Phase 1 Safety Study With Intravitreal (IVT) REGN2176-3 in Patients Aged 50 Years and Older With Wet AMD

Clinical trial NCT02061865 · COMPLETED

Trial details

NCT number: NCT02061865
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neovascular Wet Age-related Macular Degeneration (AMD)

Start date: 2014-02-01
Primary completion: 2014-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.